Search

Search Results
Results 11 - 20 of 3027 for Drug development
  • Pittcon
    Supplier Profile
    The mission of The Pittsburgh Conference on Analytical Chemistry and Applied Spectroscopy, Inc. is to sponsor and sustain educational and charitable activities for the advancement and benefit of...
  • Bruker Nano Surfaces and Metrology
    Supplier Profile
    Bruker Nano Surfaces and Metrology provides high-performance, specialized analysis and testing technology for the widest range of research and production applications. Our broad portfolio of 2D and...
  • Bruker BioAFM
    Supplier Profile
    Bruker BioAFM, former JPK Instruments AG,  is a lead­ing man­u­fac­tur­er of nano-an­a­lyt­i­cal in­stru­ments - par­tic­u­lar­ly based...
  • InProcess-LSP
    Supplier Profile
    InProcess-LSP, headquartered in Oss at Pivot Park, is a rapidly growing, innovative company founded in 2014. Backed by a team of in-house experts—comprising physicists, chemists, and software...
  • Radiolabeling Nanomaterials for the Efficient Development of Nanomedicinal Drugs
    Article - 26 Jul 2021
    This article will provide an insight into nanomaterials and how radiolabeling of these key materials can be used for the efficient development of medicinal drugs.
  • Drug Development with the DynaPro Plate Reader III
    Article - 25 Nov 2017
    The DynaPro Plate Reader III revolutionizes drug development with high-throughput DLS/SLS analysis for nanoparticle and protein characterization.
  • Nikalyte Ltd
    Supplier Profile
    Nikalyte Ltd is a leading supplier of various nanoparticles coatings for R&D and commercialization in a wide variety of application areas including cell binding, cell separation, drug delivery,...
  • Screening Drug Metabolism - Reducing Drug Development Costs
    Article - 28 Nov 2005
    Reducing drug development costs is a major issue for the pharmaceutical sector. CPI, in a collaboration with other researchers are working on an automated system for screening drug metabolism that...
  • Dynamic Light Scattering for Pharmaceutical Drug Development Screening for Promiscuous Inhibitors
    Article - 20 Apr 2005
    DLS identifies promiscuous inhibitors in drug screening by detecting aggregation at specific concentrations using Malvern Panalytical HPPS.
  • Protein-Centric Drug Development and Functional Glycomics - New Technology
    Article - 7 May 2004
    Researchers are beginning to see the potential for breakthrough in healthcare through glycomics, which studies carbohydrates, proteins and their interactions. Posted April 28 2004

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback